Detalles de la búsqueda
1.
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101).
Int J Clin Oncol
; 26(12): 2216-2223, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463869
2.
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.
BMC Cancer
; 20(1): 115, 2020 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32046667
3.
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study).
Cancer
; 124(19): 3830-3838, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30192383
4.
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
BMC Cancer
; 18(1): 946, 2018 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285770
5.
Sterilized talc pleurodesis for malignant pleural effusions: a Phase II study for investigational new drug application in Japan.
Jpn J Clin Oncol
; 48(4): 376-381, 2018 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29528450
6.
The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.
Jpn J Clin Oncol
; 48(1): 89-93, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29036303
7.
Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.
Cancer Sci
; 107(2): 162-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26577492
8.
4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
Int J Clin Oncol
; 20(3): 566-73, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25030546
9.
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
Lancet Oncol
; 15(1): 106-13, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24309370
10.
Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.
Cancer
; 119(12): 2275-81, 2013 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23558513
11.
A phase II study of pemetrexed in chemotherapy-naive elderly patients aged ≥ 75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003).
Jpn J Clin Oncol
; 43(12): 1184-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24168805
12.
A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706.
Jpn J Clin Oncol
; 41(1): 25-31, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20802006
13.
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.
Lancet Oncol
; 11(2): 121-8, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20022809
14.
Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer.
Intern Med
; 57(9): 1269-1272, 2018 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29279482
15.
Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?
Oncotarget
; 9(78): 34765-34771, 2018 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30410675
16.
Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.
Lung Cancer
; 124: 65-70, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268482
17.
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.
N Engl J Med
; 346(2): 85-91, 2002 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-11784874
18.
Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).
Int J Radiat Oncol Biol Phys
; 69(3): 786-92, 2007 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17512126
19.
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses.
Cancer Chemother Pharmacol
; 60(2): 285-93, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17136542
20.
Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug.
Med Oncol
; 24(1): 103-7, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17673819